Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Katowice
Clinical trial register · Poland

Clinical Trials in Katowice, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Poland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2705 matching records held by the registry are in this view. Synced 28 Oct 2026, 03:18 UTC
2705
Studies in scope
all four open statuses
1389
Recruiting now
open to new participants
512
Lead sponsors
across recruiting studies
Top sites
Warsaw 95 Lodz 80 Krakow 70 Poznan 67 Gdansk 59
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca27 Pfizer23 Hoffmann-La Roche20 Janssen Research & Development, LLC17 argenx16 Clear sponsor filter
Site location
Warsaw95 Lodz80 Krakow70 Poznan67 Gdansk59
All 81 locations
Target enrolment
to

Trials with a site in Katowice

27 of 2705 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Poland
Start
Recruiting
AstraZeneca
Phase 3
1,072
Bydgoszcz, Katowice, Kielce, Krakow, Ossy, Warsaw
2026-08-31
Recruiting
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
NCT07761117Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
DrugElecoglipron
AstraZeneca
Phase 3
6,950
Bialystok, Częstochowa, Gdynia, Katowice, Krakow, Poznan, Przemyśl, Radzionków
2026-08-24
Recruiting
AstraZeneca
Phase 3
7,000
Będzin, Bialystok, Czeladź, Gmina Świecie, Katowice, Kwidzyn, Lodz, Lublin
2026-08-21
Recruiting
AstraZeneca
Phase 3
1,500
Bialystok, Elblag, Gdynia, Katowice, Krakow, Legnica, Lodz, Poznan
2026-08-20
Recruiting
AstraZeneca
Phase 3
2,500
Bialystok, Elblag, Gdynia, Katowice, Krakow, Legnica, Lodz, Poznan
2026-08-19
Recruiting
AstraZeneca
Phase 3
600
Częstochowa, Gdynia, Katowice, Lodz, Lublin, Warsaw
2026-08-12
Recruiting
Ravulizumab Outcomes in Polish Patients With aHUS
NCT07399730Atypical Hemolytic Uremic Syndrome
DrugRavulizumab
AstraZeneca
Observational
80
Gdansk, Katowice, Krakow, Lodz, Poznan, Warsaw, Wroclaw
2026-06-24
Recruiting
AstraZeneca
Phase 3
245
Bydgoszcz, Częstochowa, Katowice, Krakow, Lodz, Lublin, Nadarzyn, Nowa Sól
2026-04-13
Recruiting
AstraZeneca
Phase 2
987
Bialystok, Bydgoszcz, Chęciny, Elblag, Karczew, Katowice, Komorniki, Ksawerów
2025-06-27
Recruiting
AstraZeneca
Phase 3
15,100
Bialystok, Bydgoszcz, Gdansk, Gdynia, Jelenia Góra, Katowice, Kędzierzyn-Koźle, Krakow
2025-06-04
Active, closed
AstraZeneca
Phase 3
3,103
Bialystok, Gdansk, Gdynia, Katowice, Kędzierzyn-Koźle, Krakow, Lodz, Lublin
2025-05-28
Recruiting
AstraZeneca
Observational
50
Bydgoszcz, Gdansk, Katowice, Krakow, L DZ, Lublin, Poznan, Szczecin
2025-05-15
Recruiting
AstraZeneca
Phase 3
990
Bialystok, Bydgoszcz, Chrzanów, Karczew, Katowice, Kielce, Krakow, Lodz
2025-03-18
Recruiting
AstraZeneca
Phase 3
5,000
Bialystok, Gdynia, Gmina Świecie, Jasło, Katowice, Krakow, Lodz, Lublin
2025-03-03
Active, closed
AstraZeneca
Observational
105
Bydgoszcz, Bytom, Gdansk, Katowice, Krakow, Lodz, Lublin, Poznan
2025-02-28
Active, closed
AstraZeneca
Phase 3
768
Katowice, Krakow, Lodz, Olsztyn, Poznan
2024-10-04
Recruiting
AstraZeneca
Phase 3
620
Bialystok, Katowice, Krakow, Lublin, Warsaw, Wroclaw
2024-08-12
Recruiting
AstraZeneca
Phase 3
1,018
Gdansk, Gliwice, Katowice, Krakow, Lublin, Warsaw, Wroclaw
2024-08-07
Active, closed
AstraZeneca
Phase 3
339
Katowice, Kielce, Ossy, Rzeszów, Warsaw
2024-06-29
Recruiting
AstraZeneca
Phase 3
3,850
Biała Podlaska, Bielsko-Biala, Bydgoszcz, Chrzanów, Gdansk, Gdynia, Katowice, Kazimierza Wielka
2024-04-12
Active, closed
AstraZeneca
Phase 3
594
Bielsko-Biala, Gdansk, Katowice, Krakow, Lublin, Słupsk, Warsaw
2024-03-04
Recruiting
AstraZeneca
Phase 3
5,250
Bialystok, Bydgoszcz, Chęciny, Chojnice, Częstochowa, Inowrocław, Karczew, Katowice
2024-02-21
Active, closed
AstraZeneca
Phase 3
607
Bydgoszcz, Gdansk, Katowice, Krakow, Lódz, Lublin
2022-09-12
Active, closed
AstraZeneca
Phase 3
791
Bialystok, Gliwice, Katowice, Lodz, Warsaw, Wroclaw
2022-02-18
Active, closed
AstraZeneca
Phase 3
367
Katowice, Kościan, Krakow, Lodz, Lublin, Nowa Sól, Ustroń, Warsaw
2021-06-08
Active, closed
AstraZeneca
Phase 3
640
Katowice, Krakow, Lodz, Siedlce, Warsaw
2020-10-19
Active, closed
AstraZeneca
Phase 3
724
Bydgoszcz, Elblag, Gdansk, Katowice, Lodz, Warsaw
2019-03-06
Rows per page Showing 1–27 of 27
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Polish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 28 October 2026. https://priyalifescience.com/clinical-trials-poland/city/katowice

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Poland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,705 studies in total at the last sync on 28 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 27 of those studies with a site in Katowice that also match the filters currently applied.

How many clinical trials are recruiting in Katowice?

17 of the 27 studies on this page are recruiting new participants as of the 28 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 10 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Katowice), 27 studies
PhaseStudiesRecruitingShare
Phase 3231485.2%
Observational3211.1%
Phase 2113.7%

Most active sponsors

Lead sponsors with the most studies (Katowice)
Lead sponsorStudiesRecruiting
AstraZeneca2717
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.